Highland Capital Management (Texas)’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-22,608
| Closed | -$402K | – | 367 |
|
|
2018
Q3 | $402K | Buy |
+22,608
| New | +$402K | 0.02% | 238 |
|
|
2017
Q1 | – | Sell |
-461,561
| Closed | -$1.18M | – | 330 |
|
|
2016
Q4 | $1.18M | Sell |
461,561
-3,645
| -0.8% | -$9.3K | 0.06% | 156 |
|
|
2016
Q3 | $1.44M | Buy |
465,206
+174,750
| +60% | +$540K | 0.04% | 153 |
|
|
2016
Q2 | $932K | Sell |
290,456
-152,200
| -34% | -$488K | 0.04% | 159 |
|
|
2016
Q1 | $1.37M | Sell |
442,656
-483,133
| -52% | -$1.5M | 0.06% | 155 |
|
|
2015
Q4 | $3.71M | Buy |
925,789
+228,420
| +33% | +$916K | 0.12% | 134 |
|
|
2015
Q3 | $3.19M | Sell |
697,369
-284,600
| -29% | -$1.3M | 0.09% | 154 |
|
|
2015
Q2 | $5.1M | Sell |
981,969
-17,346
| -2% | -$90K | 0.1% | 140 |
|
|
2015
Q1 | $6.26M | Buy |
999,315
+866,176
| +651% | +$5.42M | 0.13% | 118 |
|
|
2014
Q4 | $837K | Buy |
+133,139
| New | +$837K | 0.03% | 169 |
|
|
2014
Q2 | – | Sell |
-268,637
| Closed | -$6.4M | – | 315 |
|
|
2014
Q1 | $6.4M | Buy |
268,637
+176,191
| +191% | +$4.19M | 0.26% | 83 |
|
|
2013
Q4 | $987K | Sell |
92,446
-51,919
| -36% | -$554K | 0.05% | 116 |
|
|
2013
Q3 | $1.92M | Buy |
144,365
+23,456
| +19% | +$313K | 0.12% | 84 |
|
|
2013
Q2 | $1.59M | Buy |
+120,909
| New | +$1.59M | 0.12% | 83 |
|